Results 11 to 20 of about 248,997 (274)
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
Cancer Biology & Medicine, 2021 Objective: O6methylguanine-DNA methyltransferase (MGMT) promoter methylation is a biomarker widely used to predict the sensitivity of IDH-wildtype glioblastoma to temozolomide therapy.
Ruichao Chai +11 more
doaj +1 more source
Extracranial metastasis of anaplastic oligoastrocytoma
Cancer Biology & Medicine, 2018 Extracranial metastasis (ECM) of glioma is a rare condition that occurs in the internal nervous axis. A 23-year-old woman presented with anaplastic oligoastrocytoma (WHO III) in a left temporal tumor.
Zhuang Kang +8 more
doaj +1 more source
BMC Cancer, 2020 Background Glioblastomas (GBM) are therapy-resistant tumors with a profoundly immunosuppressive tumor microenvironment. Chemotherapy has shown limited efficacy against GBM.
Julio Enríquez Pérez +4 more
doaj +1 more source
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Cancer Cell International, 2021 Background Transmembrane protein with EGF-like and two follistatin-like domains 2 (TMEFF2) is a transmembrane protein in the tomoregulin family. Little research has been performed to determine whether TMEFF2 methylation is a prognostic marker in adult ...
Sidi Xie +10 more
doaj +1 more source
Frontiers in Oncology, 2022 Metabolic reprogramming is a hallmark of glioma, and sterol O-acyltransferase 1 (SOAT1) is an essential target for metabolic therapy. However, the prognostic value of SOAT1 and its association with immune infiltration has not been fully elucidated. Using
Xuyang Guo +13 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2021 BackgroundAs a critical organelle for protein and lipid synthesis, the dysfunction of endoplasmic reticulum has a significant impact on multiple biological processes of cells.
Ruoyu Huang +17 more
doaj +1 more source
Scientific Reports, 2022 Glioblastoma has remained the deadliest primary brain tumor while its current therapy offers only modest survival prolongation. Immunotherapy has failed to record notable benefits in routine glioblastoma treatment. Conventionally, immunotherapy relies on
Jan Kopecky +5 more
doaj +1 more source
Glioma Grade Prediction Using Wavelet Scattering-Based Radiomics [PDF]
in IEEE Access, vol. 8, pp. 106564-106575, 2020, 2019 Glioma grading before surgery is very critical for the prognosis prediction and treatment plan making. We present a novel wavelet scattering-based radiomic method to predict noninvasively and accurately the glioma grades. The method consists of wavelet scattering feature extraction, dimensionality reduction, and glioma grade prediction.
arxiv +1 more source
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
Frontiers in Oncology, 2019 Objectives: In the present study, we aimed to determine the candidate genes that may function as biomarkers to further distinguish patients with isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM), which are heterogeneous with respect to clinical ...
Yu-Qing Liu +13 more
doaj +1 more source
Cancer Cell International, 2019 Background The plant homeodomain (PHD) finger protein 14 (PHF14) is a vital member of PHD finger protein families. Abnormal expression of PHF14 has been identified in various cancers and is known to be implicated in the pathogenesis of tumors. This study
Shuai Wu +5 more
doaj +1 more source